Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes

NJ Hogrebe, M Ishahak, JR Millman - Cell Stem Cell, 2023 - cell.com
The generation of islet-like endocrine clusters from human pluripotent stem cells (hPSCs)
has the potential to provide an unlimited source of insulin-producing β cells for the treatment …

The physiological role of β-cell heterogeneity in pancreatic islet function

RKP Benninger, V Kravets - Nature Reviews Endocrinology, 2022 - nature.com
Endocrine cells within the pancreatic islets of Langerhans are heterogeneous in terms of
transcriptional profile, protein expression and the regulation of hormone release. Even …

Engineering islets from stem cells for advanced therapies of diabetes

J Siehler, AK Blöchinger, M Meier… - Nature reviews Drug …, 2021 - nature.com
Diabetes mellitus is a metabolic disorder that affects more than 460 million people
worldwide. Type 1 diabetes (T1D) is caused by autoimmune destruction of β-cells, whereas …

Cellular and molecular mechanisms coordinating pancreas development

A Bastidas-Ponce, K Scheibner, H Lickert… - …, 2017 - journals.biologists.com
The pancreas is an endoderm-derived glandular organ that participates in the regulation of
systemic glucose metabolism and food digestion through the function of its endocrine and …

Targeted pharmacological therapy restores β-cell function for diabetes remission

S Sachs, A Bastidas-Ponce, S Tritschler, M Bakhti… - Nature …, 2020 - nature.com
Dedifferentiation of insulin-secreting β cells in the islets of Langerhans has been proposed
to be a major mechanism of β-cell dysfunction. Whether dedifferentiated β cells can be …

Delineating mouse β-cell identity during lifetime and in diabetes with a single cell atlas

K Hrovatin, A Bastidas-Ponce, M Bakhti, L Zappia… - Nature …, 2023 - nature.com
Although multiple pancreatic islet single-cell RNA-sequencing (scRNA-seq) datasets have
been generated, a consensus on pancreatic cell states in development, homeostasis and …

mTORC1 signaling: a double-edged sword in diabetic β cells

A Ardestani, B Lupse, Y Kido, G Leibowitz, K Maedler - Cell Metabolism, 2018 - cell.com
The mechanistic target of rapamycin complex 1 (mTORC1) is a central regulator of metabolic
and nutrient cues that integrates environmental inputs into downstream signaling pathways …

NKX6. 1 transcription factor: a crucial regulator of pancreatic β cell development, identity, and proliferation

II Aigha, EM Abdelalim - Stem cell research & therapy, 2020 - Springer
Understanding the biology underlying the mechanisms and pathways regulating pancreatic
β cell development is necessary to understand the pathology of diabetes mellitus (DM) …

Stem cell transplantation therapy and neurological disorders: current status and future perspectives

MM Rahman, MR Islam, MT Islam, M Harun-Or-Rashid… - Biology, 2022 - mdpi.com
Simple Summary This review highlights the scope of available treatment options for
neurological diseases, especially stem cell transplantation therapy, which provides new …

PDX1LOW MAFALOW β-cells contribute to islet function and insulin release

D Nasteska, NHF Fine, FB Ashford, F Cuozzo… - Nature …, 2021 - nature.com
Transcriptionally mature and immature β-cells co-exist within the adult islet. How such
diversity contributes to insulin release remains poorly understood. Here we show that subtle …